Acute kidney injury associated with immune checkpoint inhibitor therapy: incidence, risk factors and outcomes

BACKGROUND: Immune checkpoint inhibitors (ICPi) are a novel and promising anti-cancer therapy. There are limited data on the incidence, risk factors and outcomes of acute kidney injury (AKI) in patients receiving ICPi. METHODS: We conducted a cohort study of patients receiving ICPi at our center bet...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Immunother Cancer
Main Authors: Meraz-Muñoz, Alejandro, Amir, Eitan, Ng, Pamela, Avila-Casado, Carmen, Ragobar, Claire, Chan, Christopher, Kim, Joseph, Wald, Ron, Kitchlu, Abhijat
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2020
Assuntos:
Clinical/Translational Cancer Immunotherapy
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7326260/
https://ncbi.nlm.nih.gov/pubmed/32601079
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2019-000467
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados